Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Ray
Kevin Fox

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
The American Journal of Cardiology|July 23, 2014
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)Anders M Greve, Morten Dalsgaard, Casper N Bang, et al.
Heart (British Cardiac Society)|September 14, 2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EFNikolaus Jander, Willibald Hochholzer, Beat A Kaufmann, et al.
JACC. Cardiovascular Imaging|September 23, 2019
Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer TherapyJenica N Upshaw, Brian Finkelman, Rebecca A Hubbard, et al.
The American Journal of Cardiology|November 25, 2010
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)Eva Gerdts, Anne Bjørhovde Rossebø, Terje Rolf Pedersen, et al.
The American Journal of Cardiology|April 3, 2007
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) studyAnne B Rossebø, Terje R Pedersen, Christopher Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
International Journal of Cardiology|December 2, 2014
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS studyAnders M Greve, Casper N Bang, Ronan M G Berg, et al.
The New England Journal of Medicine|September 4, 2008
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosisAnne B Rossebø, Terje R Pedersen, Kurt Boman, et al.
Nature Communications|May 3, 2025
Liposomal lipid nanoparticles for extrahepatic delivery of mRNAMiffy Hok Yan Cheng, Yao Zhang, Kevin Fox, et al.
Heart (British Cardiac Society)|August 24, 2013
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosisNikolaus Jander, Christa Gohlke-Bärwolf, Edda Bahlmann, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
The American Journal of Cardiology|July 23, 2014
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study)Anders M Greve, Morten Dalsgaard, Casper N Bang, et al.
Heart (British Cardiac Society)|September 14, 2014
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EFNikolaus Jander, Willibald Hochholzer, Beat A Kaufmann, et al.
JACC. Cardiovascular Imaging|September 23, 2019
Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer TherapyJenica N Upshaw, Brian Finkelman, Rebecca A Hubbard, et al.
The American Journal of Cardiology|November 25, 2010
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)Eva Gerdts, Anne Bjørhovde Rossebø, Terje Rolf Pedersen, et al.
The American Journal of Cardiology|April 3, 2007
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) studyAnne B Rossebø, Terje R Pedersen, Christopher Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
International Journal of Cardiology|December 2, 2014
Resting heart rate and risk of adverse cardiovascular outcomes in asymptomatic aortic stenosis: the SEAS studyAnders M Greve, Casper N Bang, Ronan M G Berg, et al.
The New England Journal of Medicine|September 4, 2008
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosisAnne B Rossebø, Terje R Pedersen, Kurt Boman, et al.
Nature Communications|May 3, 2025
Liposomal lipid nanoparticles for extrahepatic delivery of mRNAMiffy Hok Yan Cheng, Yao Zhang, Kevin Fox, et al.
Heart (British Cardiac Society)|August 24, 2013
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosisNikolaus Jander, Christa Gohlke-Bärwolf, Edda Bahlmann, et al.
Pageof 20